Icon PLC (ICLR)
288.33
-3.49
(-1.20%)
USD |
NASDAQ |
Apr 19, 16:00
288.27
-0.06
(-0.02%)
After-Hours: 20:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 23.79B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | 37.06% |
Valuation | |
PE Ratio | 39.07 |
PE Ratio (Forward) | Upgrade |
PS Ratio | 2.937 |
Price to Book Value | 2.574 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.4086 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 43.85% |
Profile
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland. |
URL | https://www.iconplc.com |
Investor Relations URL | https://investor.iconplc.com/ |
HQ State/Province | N/A |
Sector | Health Care |
Industry | Life Sciences Tools & Services |
Equity Style | Mid Cap/Growth |
Next Earnings Release | Apr. 24, 2024 |
Last Earnings Release | Feb. 21, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland. |
URL | https://www.iconplc.com |
Investor Relations URL | https://investor.iconplc.com/ |
HQ State/Province | N/A |
Sector | Health Care |
Industry | Life Sciences Tools & Services |
Equity Style | Mid Cap/Growth |
Next Earnings Release | Apr. 24, 2024 |
Last Earnings Release | Feb. 21, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |